|
gptkbp:instanceOf
|
gptkb:medical_imaging_technique
|
|
gptkbp:administeredBy
|
intravenous injection
|
|
gptkbp:alternativeName
|
gptkb:FDG-PET
fluorodeoxyglucose PET scan
|
|
gptkbp:approvedBy
|
gptkb:FDA_in_1997
|
|
gptkbp:contraindication
|
pregnant women
patients with severe hyperglycemia
|
|
gptkbp:detects
|
glucose uptake
metabolic activity
|
|
gptkbp:developedBy
|
1970s
|
|
gptkbp:duration
|
1-2 hours
|
|
gptkbp:inventedBy
|
gptkb:Edward_J._Hoffman
gptkb:Michael_E._Phelps
|
|
gptkbp:measures
|
standardized uptake value
|
|
gptkbp:notRecommendedFor
|
children unless necessary
|
|
gptkbp:performedAt
|
hospitals
imaging centers
|
|
gptkbp:produces
|
3D images
|
|
gptkbp:regulates
|
gptkb:FDA
|
|
gptkbp:requires
|
specialized equipment
fasting before procedure
radiotracer production facility
|
|
gptkbp:sideEffect
|
radiation exposure
allergic reaction (rare)
|
|
gptkbp:usedFor
|
cancer diagnosis
cardiac imaging
neurological disorder assessment
cancer staging
|
|
gptkbp:uses
|
gptkb:positron_emission_tomography
fluorodeoxyglucose
|
|
gptkbp:bfsParent
|
gptkb:GLUT1_transporter
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
PET scan with FDG
|